Skip to content

Clinical trials

Phase 2 Cystic Fibrosis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Phase 2 Country / region: Netherlands Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20092
20111
20141
20161
20173
20193
20211
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated4
AbbVie2
Boehringer Ingelheim2
Lakefront Biotherapeutics NV2
Amgen1
AstraZeneca1
Bayer1
Corbus Pharmaceuticals Inc.1
Gilead Sciences1
Kors van der Ent1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis18
Bronchiectasis1
Exocrine Pancreatic Insufficiency1
Genetic Diseases, Inborn1
Infant, Newborn, Diseases1
Lung Diseases1
Pancreatic Diseases1
Pseudomonas Infections1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.